Tumor-specific gene therapy for pancreatic cancer using human neural stem cells encoding carboxylesterase
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Sung S. | - |
dc.contributor.author | Yoon, Kichul | - |
dc.contributor.author | Choi, Seon-A | - |
dc.contributor.author | Yoon, Seung-Bin | - |
dc.contributor.author | Kim, Seung U. | - |
dc.contributor.author | Lee, Hong J. | - |
dc.date.accessioned | 2023-03-08T16:49:37Z | - |
dc.date.available | 2023-03-08T16:49:37Z | - |
dc.date.issued | 2016-11 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/64134 | - |
dc.description.abstract | Advanced pancreatic cancer is one of the most lethal malignant human diseases lacking effective treatment. Its extremely low survival rate necessitates development of novel therapeutic approach. Human neural stem cells (NSCs) are known to have tumor-tropic effect. We genetically engineered them to express rabbit carboxyl esterase (F3.CE), which activates prodrug CPT-11(irinotecan) into potent metabolite SN-38. We found significant inhibition of the growth of BxPC3 human pancreatic cancer cell line in vitro by F3. CE in presence of CPT-11. Apoptosis was also markedly increased in BxPC3 cells treated with F3. CE and CPT-11. The ligand VEGF and receptor VEGF-1(Flt1) were identified to be the relevant tumor-tropic chemoattractant. We confirmed in vivo that in mice injected with BxPC3 on their skin, there was significant reduction of tumor size in those treated with both F3. CE and BxPC3 adjacent to the cancer mass. Administration of F3. CE in conjunction with CPT-11 could be a new possibility as an effective treatment regimen for patients suffering from advanced pancreatic cancer. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | IMPACT JOURNALS LLC | - |
dc.title | Tumor-specific gene therapy for pancreatic cancer using human neural stem cells encoding carboxylesterase | - |
dc.type | Article | - |
dc.identifier.doi | 10.18632/oncotarget.12173 | - |
dc.identifier.bibliographicCitation | ONCOTARGET, v.7, no.46, pp 75319 - 75327 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000389632800070 | - |
dc.identifier.scopusid | 2-s2.0-84996940036 | - |
dc.citation.endPage | 75327 | - |
dc.citation.number | 46 | - |
dc.citation.startPage | 75319 | - |
dc.citation.title | ONCOTARGET | - |
dc.citation.volume | 7 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | CPT-11 | - |
dc.subject.keywordAuthor | carboxyl esterase (CE) | - |
dc.subject.keywordAuthor | gene therapy | - |
dc.subject.keywordAuthor | human neural stem cell | - |
dc.subject.keywordAuthor | pancreatic cancer | - |
dc.subject.keywordPlus | BREAST-CANCER | - |
dc.subject.keywordPlus | GLIOMA MODEL | - |
dc.subject.keywordPlus | EXPRESSING CARBOXYLESTERASE | - |
dc.subject.keywordPlus | CYTOSINE DEAMINASE | - |
dc.subject.keywordPlus | BRAIN-TUMORS | - |
dc.subject.keywordPlus | TARGET | - |
dc.subject.keywordPlus | TROPISM | - |
dc.subject.keywordPlus | DELIVER | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | CPT-11 | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.